Oral ivermectin is the most widely used next step when topical permethrin cream fails to clear scabies, and it can be taken alone or paired with a repeat round of permethrin for stubborn cases. But before switching treatments, it is worth figuring out whether the permethrin actually failed or whether something went wrong with how it was used. True drug resistance in scabies mites does exist, yet application mistakes and untreated household contacts account for a surprising share of what looks like treatment failure. Understanding the difference changes what you should do next.
Why Permethrin Fails More Often Than It Should
Permethrin 5% cream remains a first-line scabies treatment in most countries, and when applied correctly it still works well for the majority of people. The problem is that “applied correctly” involves a set of steps many patients never fully follow. A multicenter study examining risk factors for treatment failure found three independent predictors, all related to how the cream was used rather than to the drug itself: not applying it to the entire body from the neck down, not reapplying after hand-washing, and not reading the instruction sheet that came with the medication. The odds of failure jumped dramatically with each of these mistakes.1PubMed Central. Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study In practice, many people wash their hands multiple times during the eight-to-fourteen-hour overnight treatment and never think to recoat them, leaving the most commonly affected skin unprotected.
That said, genuine resistance to permethrin is a growing concern. Research has identified mutations in the mites’ voltage-gated sodium channels, the exact molecular target permethrin acts on. These mutations can push the channel into a closed state, which reduces how well permethrin binds. The mites also show increased activity of an enzyme called glutathione S-transferase, which helps them break down and eliminate the drug faster.2PubMed Central. Resistance and Pseudo-resistance to permethrin: the importance of controlling scabies Clinical studies, lab work, and case reports all point to meaningful permethrin resistance in human scabies.3PubMed Central. Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions Researchers have proposed the voltage-sensitive sodium channel gene as a molecular marker for tracking this resistance.4Jurnal Ners. Role of VSSC Gene as a Marker of Sarcoptes scabiei Resistance to Permethrin: A Narrative Review
So when permethrin does not work, the honest answer is sometimes “try it again, but do it properly this time.” If you already followed the instructions to the letter, applied cream from jawline to soles of feet, treated under fingernails, left it on for the full duration, repeated it a week later, and washed all bedding and clothing, then you are looking at either true resistance or reinfestation from an untreated contact. That is when alternative treatments come in.
Oral Ivermectin as the Go-To Alternative
Ivermectin taken by mouth is the treatment most dermatologists reach for when permethrin fails. It works through a completely different mechanism than permethrin, targeting chloride channels in the mites’ nerve and muscle cells rather than sodium channels. This means permethrin-resistant mites are not automatically resistant to ivermectin. A standard regimen involves two doses taken about a week apart. In a randomized trial comparing two doses of oral ivermectin against a single application of permethrin, the cure rates were comparable, around 91% for ivermectin and 93% for permethrin in mild-to-moderate cases.5PubMed Central. Efficacy of Two Doses of Ivermectin Tablet in Treatment of Scabies in Comparison to Once Application of 5% Permethrin Lotion – A Randomized Controlled Trial
Ivermectin has practical advantages beyond its different mechanism. It is a pill, so there is no risk of the application errors that doom so many permethrin treatments. You do not have to worry about missing patches of skin or washing it off your hands. The drug is generally well tolerated, with side effects mostly limited to mild headache and occasional nausea. It is approved for adults and children weighing more than 15 kilograms. For younger children, the data is more limited, though a study of 170 infants and children under 15 kg treated with oral ivermectin found only seven mild adverse events and no serious ones.6PubMed. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study Still, use in that age group remains off-label, and a pediatrician should be involved in the decision.
Combining Ivermectin and Permethrin for Stubborn Cases
When scabies is severe or has resisted treatment, some clinicians use oral ivermectin and topical permethrin together rather than choosing one or the other. The logic is straightforward: attack the mites through two pathways at once. A trial published in the New England Journal of Medicine tested this combination in patients with severe scabies and found cure rates around 75% to 82% depending on the ivermectin dose used.7PubMed. Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies Those numbers might seem modest, but the patients in these trials had severe disease, the kind where mites are present in large numbers and the skin is heavily crusted.
In children with persistent scabies, combination therapy showed clearer advantages over permethrin alone. An observational study found that kids receiving both treatments reached a 50% reduction in itching roughly two and a half days faster, and their cure rates at four weeks were higher, about 84% versus 66%. Recurrence at three months was also lower in the combination group.8PubMed Central. Efficacy of combination therapy with oral Ivermectin and topical permethrin versus permethrin monotherapy in pediatric patients with persistent scabies: a propensity score-adjusted observational study Side effects were mild and self-limiting, mostly a temporary flare of itching and occasional headache. For people who have already failed one or two rounds of single-agent treatment, combination therapy is a reasonable escalation.
Other Topical Options Worth Knowing About
Ivermectin is the headline alternative, but several other topical treatments exist. Which ones are available depends heavily on where you live and what your doctor can prescribe or recommend.
Spinosad
Spinosad 0.9% topical suspension is the newest option and one of the more promising. In two randomized, double-blind trials, a single application cured about 78% of patients at day 28, compared to roughly 40% for the vehicle (placebo) cream.9PubMed. Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies It is the first scabicide designed as a single-dose treatment, which sidesteps the compliance issues that plague permethrin. Spinosad is derived from a soil bacterium, shows very little absorption through the skin, and has been approved for patients four years and older.10PubMed. Spinosad topical suspension (0.9%): a new topical treatment for scabies If you are in the United States, your dermatologist can prescribe it by brand name (Natroba), though insurance coverage varies.
Benzyl Benzoate
Benzyl benzoate is widely used in many countries outside the United States and is often available over the counter. A meta-analysis of randomized trials found that permethrin works faster in the first week, with cure rates about 30% higher at that early timepoint. By later follow-up visits, however, the difference between permethrin and benzyl benzoate narrowed and was no longer statistically significant.11PubMed Central. Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The main downsides are skin irritation, which can be intense, and the need for repeat applications. It is less elegant than a single-dose treatment but works well enough to remain a global workhorse.
Sulfur Ointment
Sulfur ointment, typically in a 6% to 10% concentration, is one of the oldest scabies treatments still in use. It is inexpensive, safe during pregnancy, and available in many low-resource settings. Research supports it as a safe and effective topical option.12PubMed. Comparison of sulfur ointment and permethrin treatments in scabies The drawback is cosmetic: it smells bad, stains clothing, and needs to be applied on three consecutive nights. For people who cannot tolerate or access other treatments, it gets the job done.
Crotamiton
Crotamiton (Eurax) has anti-itch properties that make it appealing, but its cure rates are substantially lower than permethrin’s. In a trial comparing the two in children, four-week cure rates were about 60% for crotamiton versus 89% for permethrin.13PubMed. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children Part of the problem is that crotamiton kills adult mites but does not reliably kill eggs and larvae, so a second application a week or two later is essential.14PubMed Central. Comparative Efficacy of Topical Pertmehrin, Crotamiton and Sulfur Ointment in Treatment of Scabies It is not a first-choice alternative when permethrin has failed, but it can serve as an add-on for itch relief.
Malathion
Malathion 0.5% lotion is sometimes used for scabies, particularly when treating the scalp or hairy areas where cream is impractical.15PubMed. Malathion for head lice and scabies: treatment and safety considerations In a comparative study, two applications of malathion lotion cured about 68% of patients at four weeks.16PubMed. The efficacy of topical ivermectin versus malation 0.5% lotion for the treatment of scabies That is not spectacular, and malathion is not widely prescribed for this purpose, but it fills a niche when other topicals are unavailable or poorly suited to the body area involved.
Are You Sure It Is Still Scabies?
This is the question that trips up more people than almost any other. Itching can persist for weeks after successful treatment, and many patients go through unnecessary extra rounds of medication because they mistake lingering symptoms for ongoing infestation. The culprit is usually a hypersensitivity reaction to dead mite proteins and fecal material left behind in the skin. Your immune system was ramped up to fight the infestation, and it does not switch off the moment the last mite dies.
Post-scabietic nodules, firm itchy bumps that can appear at sites where mites were concentrated, are a well-recognized phenomenon. These can persist for months and look almost identical to active scabies nodules.17PubMed Central. Prolonged Post-Scabietic Pruritus: Clinical Characteristics and Unmet Management Needs in a Real-World Cohort A dermatologist can often distinguish them from active disease using dermatoscopy, looking for the absence of live mites and burrows. Treating post-scabietic itch with more scabicide accomplishes nothing and may irritate the skin further. Topical corticosteroids, antihistamines, and time are the appropriate remedies.
If you are unsure whether your treatment worked, a reasonable rule of thumb is this: if no new burrows are appearing and the itching is gradually improving rather than spreading, the mites are probably gone. If itching is getting worse, appearing in new body areas, or new household members are developing symptoms, reinfestation or treatment failure is more likely.
The Untreated Roommate Problem
One of the most common reasons scabies appears to resist treatment is that the patient gets reinfested by someone in their household who was never treated. Scabies mites spread through prolonged skin-to-skin contact, and people can carry the mites for weeks before developing symptoms. A case report illustrating this pattern described a man who repeatedly failed treatment until investigation revealed that his wife was an asymptomatic carrier who had never been treated.18PubMed Central. The Itchy Truth About Scabies: A Case of Asymptomatic Carrier Transmission and Treatment Failure
This is why every treatment guideline emphasizes simultaneous treatment of all close contacts, not just the person scratching. Everyone in the household should be treated on the same day, whether they have symptoms or not. Sexual partners and anyone who has had prolonged physical contact should be included. In institutional settings like nursing homes, the challenge is even greater because dozens of residents and staff may need coordinated treatment.19PubMed Central. Infected with Scabies Again? Focus in Management in Long-Term Care Facilities Environmental measures, washing bedding and clothing in hot water and drying on high heat, or bagging items that cannot be washed for at least 72 hours, help eliminate any mites that have crawled off the body.
When Scabies Leads to Skin Infections
Scratching creates tiny breaks in the skin, and scabies burrows themselves provide highways for bacteria. Secondary bacterial infections are common, especially in children and in tropical climates where both scabies and bacterial pathogens are prevalent. The bacteria most frequently found in infected scabies lesions include Staphylococcus aureus and group A streptococci, along with various anaerobic bacteria.20PubMed Central. Microbiology of secondary bacterial infection in scabies lesions There is also evidence that scabies mites produce proteins that suppress part of the immune response, which may help bacteria thrive in and around the burrows.21PubMed Central. Scabies with Secondary Infection Resembling Kerion-Type Tinea Capitis
If you notice pus, honey-colored crusting, spreading redness, or warmth around scabies lesions, you likely need oral antibiotics in addition to scabies treatment. Left unchecked, streptococcal skin infection from scabies can, in rare cases, trigger kidney inflammation. This is more of a concern in endemic regions, but it underscores why getting scabies properly treated sooner rather than later matters.
Scabies During Pregnancy and in Young Children
Pregnancy narrows the treatment options considerably. Permethrin 5% cream is considered the safest topical choice for pregnant women. Studies in animals showed no fetal harm, and a prospective comparison involving over a hundred pregnant women exposed to permethrin found no increase in miscarriages, birth defects, or preterm delivery.22PubMed Central. Scabies-infested pregnant women: A critical therapeutic challenge When permethrin does not work during pregnancy, options become limited. Oral ivermectin is generally avoided in pregnancy because safety data in pregnant women is scarce. Sulfur ointment has a long history of use in pregnancy and is typically the fallback.
For infants and very young children, permethrin is the standard first-line treatment, applied from the scalp down (unlike in adults, who start at the neck). If that fails, the decision to use oral ivermectin in a child under 15 kg should involve a specialist. Spinosad is approved only for children four and older. Sulfur ointment can be used in infants, though it is messy and requires multiple applications.
The Emotional Weight of Persistent Scabies
Scabies that will not go away takes a toll that goes beyond skin deep. The relentless nighttime itch disrupts sleep, and visible lesions carry a stigma that can affect work, school, and relationships. A cross-sectional study found that longer symptom duration, nighttime itching, and visible skin lesions were all associated with higher levels of disease-related fear in scabies patients.23PubMed Central. The Impact of Disease-Related Fear and Internalized Stigma on Quality of Life in Patients with Scabies: A Cross-Sectional Study People dealing with treatment-resistant scabies often feel embarrassed, anxious about infecting others, and frustrated with a medical system that sometimes treats their condition as trivial. If you find yourself in this situation, know that the emotional difficulty is a recognized part of the disease, not a personal weakness, and that persistent scabies is a genuine medical challenge that dermatologists encounter regularly.
What Is in the Pipeline
Moxidectin, a drug already approved for treating river blindness, is generating interest as a potential single-dose oral treatment for scabies. In a pig model of scabies, a single dose of moxidectin cleared mites in all treated animals by day 14 and kept them mite-free through the end of the study at day 47. By comparison, two doses of ivermectin achieved full clearance in only half the treated pigs by the same timepoint. The difference comes down to how long the drug sticks around: moxidectin persisted roughly nine times longer in the skin than ivermectin, long enough to cover the entire mite life cycle from egg to adult.24PLoS Neglected Tropical Diseases. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model Human clinical trials are still needed, but the early data is encouraging enough that moxidectin is considered one of the most promising candidates for scabies treatment in the coming years. A single-dose oral cure would be a meaningful advance for endemic communities where multi-dose regimens and topical creams face real compliance barriers.